Flu RNA Vaccines Market, Global Outlook and Forecast 2023-2029

Report ID: MMG63223 | Category: Pharma & Healthcare | Pages: 77 | Format: PDF | Published Date: March 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The major advantage of Flu RNA Vaccines is that scientist need not to use the live cells for the vaccine preparation as such the RNA can be produced in the laboratory from a DNA template using readily available materials which can be a easy and fast weapon to fight against the new outbreaks and the existing infectious diseases.
This report aims to provide a comprehensive presentation of the global market for Flu RNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu RNA Vaccines. This report contains market size and forecasts of Flu RNA Vaccines in global, including the following market information:
Global Flu RNA Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Flu RNA Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Flu RNA Vaccines companies in 2022 (%)
The global Flu RNA Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Non-Replicating mRNA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Flu RNA Vaccines include Sanofi Pasteur Inc., AstraZeneca, CSL Ltd., Abbott, GlaxoSmithKline Plc., Serum Institute of India Pvt. Ltd., Pfizer, BioNTech and F.Hoffman La Roche Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Flu RNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Flu RNA Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Type, 2022 (%)
    Non-Replicating mRNA
    In Vivo Self-Replicating mRNA
    In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
    Others
Global Flu RNA Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Vaccination Center
    Specialized Clinics
    Hospital Pharmacy
    Others
Global Flu RNA Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Flu RNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Flu RNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Flu RNA Vaccines revenues share in global market, 2022 (%)
Key companies Flu RNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Flu RNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Sanofi Pasteur Inc.
    AstraZeneca
    CSL Ltd.
    Abbott
    GlaxoSmithKline Plc.
    Serum Institute of India Pvt. Ltd.
    Pfizer
    BioNTech
    F.Hoffman La Roche Ltd
    Novartis
    Sinnovac Biotech Ltd
    Moderna Therapeutics
    CureVac
Outline of Major Chapters:
Chapter 1: Introduces the definition of Flu RNA Vaccines, market overview.
Chapter 2: Global Flu RNA Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Flu RNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Flu RNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Flu RNA Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Flu RNA Vaccines Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Flu RNA Vaccines Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Flu RNA Vaccines Overall Market Size
    2.1 Global Flu RNA Vaccines Market Size: 2022 VS 2029
    2.2 Global Flu RNA Vaccines Revenue, Prospects & Forecasts: 2018-2029
    2.3 Global Flu RNA Vaccines Sales: 2018-2029
3 Company Landscape
    3.1 Top Flu RNA Vaccines Players in Global Market
    3.2 Top Global Flu RNA Vaccines Companies Ranked by Revenue
    3.3 Global Flu RNA Vaccines Revenue by Companies
    3.4 Global Flu RNA Vaccines Sales by Companies
    3.5 Global Flu RNA Vaccines Price by Manufacturer (2018-2023)
    3.6 Top 3 and Top 5 Flu RNA Vaccines Companies in Global Market, by Revenue in 2022
    3.7 Global Manufacturers Flu RNA Vaccines Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Flu RNA Vaccines Players in Global Market
        3.8.1 List of Global Tier 1 Flu RNA Vaccines Companies
        3.8.2 List of Global Tier 2 and Tier 3 Flu RNA Vaccines Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Flu RNA Vaccines Market Size Markets, 2022 & 2029
        4.1.2 Non-Replicating mRNA
        4.1.3 In Vivo Self-Replicating mRNA
        4.1.4 In Vitro Dendritic Cell Non-Replicating mRNA Vaccine
        4.1.5 Others
    4.2 By Type - Global Flu RNA Vaccines Revenue & Forecasts
        4.2.1 By Type - Global Flu RNA Vaccines Revenue, 2018-2023
        4.2.2 By Type - Global Flu RNA Vaccines Revenue, 2024-2029
        4.2.3 By Type - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
    4.3 By Type - Global Flu RNA Vaccines Sales & Forecasts
        4.3.1 By Type - Global Flu RNA Vaccines Sales, 2018-2023
        4.3.2 By Type - Global Flu RNA Vaccines Sales, 2024-2029
        4.3.3 By Type - Global Flu RNA Vaccines Sales Market Share, 2018-2029
    4.4 By Type - Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Flu RNA Vaccines Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Vaccination Center
        5.1.4 Specialized Clinics
        5.1.5 Hospital Pharmacy
        5.1.6 Others
    5.2 By Application - Global Flu RNA Vaccines Revenue & Forecasts
        5.2.1 By Application - Global Flu RNA Vaccines Revenue, 2018-2023
        5.2.2 By Application - Global Flu RNA Vaccines Revenue, 2024-2029
        5.2.3 By Application - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
    5.3 By Application - Global Flu RNA Vaccines Sales & Forecasts
        5.3.1 By Application - Global Flu RNA Vaccines Sales, 2018-2023
        5.3.2 By Application - Global Flu RNA Vaccines Sales, 2024-2029
        5.3.3 By Application - Global Flu RNA Vaccines Sales Market Share, 2018-2029
    5.4 By Application - Global Flu RNA Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
    6.1 By Region - Global Flu RNA Vaccines Market Size, 2022 & 2029
    6.2 By Region - Global Flu RNA Vaccines Revenue & Forecasts
        6.2.1 By Region - Global Flu RNA Vaccines Revenue, 2018-2023
        6.2.2 By Region - Global Flu RNA Vaccines Revenue, 2024-2029
        6.2.3 By Region - Global Flu RNA Vaccines Revenue Market Share, 2018-2029
    6.3 By Region - Global Flu RNA Vaccines Sales & Forecasts
        6.3.1 By Region - Global Flu RNA Vaccines Sales, 2018-2023
        6.3.2 By Region - Global Flu RNA Vaccines Sales, 2024-2029
        6.3.3 By Region - Global Flu RNA Vaccines Sales Market Share, 2018-2029
    6.4 North America
        6.4.1 By Country - North America Flu RNA Vaccines Revenue, 2018-2029
        6.4.2 By Country - North America Flu RNA Vaccines Sales, 2018-2029
        6.4.3 US Flu RNA Vaccines Market Size, 2018-2029
        6.4.4 Canada Flu RNA Vaccines Market Size, 2018-2029
        6.4.5 Mexico Flu RNA Vaccines Market Size, 2018-2029
    6.5 Europe
        6.5.1 By Country - Europe Flu RNA Vaccines Revenue, 2018-2029
        6.5.2 By Country - Europe Flu RNA Vaccines Sales, 2018-2029
        6.5.3 Germany Flu RNA Vaccines Market Size, 2018-2029
        6.5.4 France Flu RNA Vaccines Market Size, 2018-2029
        6.5.5 U.K. Flu RNA Vaccines Market Size, 2018-2029
        6.5.6 Italy Flu RNA Vaccines Market Size, 2018-2029
        6.5.7 Russia Flu RNA Vaccines Market Size, 2018-2029
        6.5.8 Nordic Countries Flu RNA Vaccines Market Size, 2018-2029
        6.5.9 Benelux Flu RNA Vaccines Market Size, 2018-2029
    6.6 Asia
        6.6.1 By Region - Asia Flu RNA Vaccines Revenue, 2018-2029
        6.6.2 By Region - Asia Flu RNA Vaccines Sales, 2018-2029
        6.6.3 China Flu RNA Vaccines Market Size, 2018-2029
        6.6.4 Japan Flu RNA Vaccines Market Size, 2018-2029
        6.6.5 South Korea Flu RNA Vaccines Market Size, 2018-2029
        6.6.6 Southeast Asia Flu RNA Vaccines Market Size, 2018-2029
        6.6.7 India Flu RNA Vaccines Market Size, 2018-2029
    6.7 South America
        6.7.1 By Country - South America Flu RNA Vaccines Revenue, 2018-2029
        6.7.2 By Country - South America Flu RNA Vaccines Sales, 2018-2029
        6.7.3 Brazil Flu RNA Vaccines Market Size, 2018-2029
        6.7.4 Argentina Flu RNA Vaccines Market Size, 2018-2029
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Flu RNA Vaccines Revenue, 2018-2029
        6.8.2 By Country - Middle East & Africa Flu RNA Vaccines Sales, 2018-2029
        6.8.3 Turkey Flu RNA Vaccines Market Size, 2018-2029
        6.8.4 Israel Flu RNA Vaccines Market Size, 2018-2029
        6.8.5 Saudi Arabia Flu RNA Vaccines Market Size, 2018-2029
        6.8.6 UAE Flu RNA Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
    7.1 Sanofi Pasteur Inc.
        7.1.1 Sanofi Pasteur Inc. Company Summary
        7.1.2 Sanofi Pasteur Inc. Business Overview
        7.1.3 Sanofi Pasteur Inc. Flu RNA Vaccines Major Product Offerings
        7.1.4 Sanofi Pasteur Inc. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.1.5 Sanofi Pasteur Inc. Key News & Latest Developments
    7.2 AstraZeneca
        7.2.1 AstraZeneca Company Summary
        7.2.2 AstraZeneca Business Overview
        7.2.3 AstraZeneca Flu RNA Vaccines Major Product Offerings
        7.2.4 AstraZeneca Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.2.5 AstraZeneca Key News & Latest Developments
    7.3 CSL Ltd.
        7.3.1 CSL Ltd. Company Summary
        7.3.2 CSL Ltd. Business Overview
        7.3.3 CSL Ltd. Flu RNA Vaccines Major Product Offerings
        7.3.4 CSL Ltd. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.3.5 CSL Ltd. Key News & Latest Developments
    7.4 Abbott
        7.4.1 Abbott Company Summary
        7.4.2 Abbott Business Overview
        7.4.3 Abbott Flu RNA Vaccines Major Product Offerings
        7.4.4 Abbott Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.4.5 Abbott Key News & Latest Developments
    7.5 GlaxoSmithKline Plc.
        7.5.1 GlaxoSmithKline Plc. Company Summary
        7.5.2 GlaxoSmithKline Plc. Business Overview
        7.5.3 GlaxoSmithKline Plc. Flu RNA Vaccines Major Product Offerings
        7.5.4 GlaxoSmithKline Plc. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.5.5 GlaxoSmithKline Plc. Key News & Latest Developments
    7.6 Serum Institute of India Pvt. Ltd.
        7.6.1 Serum Institute of India Pvt. Ltd. Company Summary
        7.6.2 Serum Institute of India Pvt. Ltd. Business Overview
        7.6.3 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Major Product Offerings
        7.6.4 Serum Institute of India Pvt. Ltd. Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.6.5 Serum Institute of India Pvt. Ltd. Key News & Latest Developments
    7.7 Pfizer
        7.7.1 Pfizer Company Summary
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Flu RNA Vaccines Major Product Offerings
        7.7.4 Pfizer Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.7.5 Pfizer Key News & Latest Developments
    7.8 BioNTech
        7.8.1 BioNTech Company Summary
        7.8.2 BioNTech Business Overview
        7.8.3 BioNTech Flu RNA Vaccines Major Product Offerings
        7.8.4 BioNTech Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.8.5 BioNTech Key News & Latest Developments
    7.9 F.Hoffman La Roche Ltd
        7.9.1 F.Hoffman La Roche Ltd Company Summary
        7.9.2 F.Hoffman La Roche Ltd Business Overview
        7.9.3 F.Hoffman La Roche Ltd Flu RNA Vaccines Major Product Offerings
        7.9.4 F.Hoffman La Roche Ltd Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.9.5 F.Hoffman La Roche Ltd Key News & Latest Developments
    7.10 Novartis
        7.10.1 Novartis Company Summary
        7.10.2 Novartis Business Overview
        7.10.3 Novartis Flu RNA Vaccines Major Product Offerings
        7.10.4 Novartis Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.10.5 Novartis Key News & Latest Developments
    7.11 Sinnovac Biotech Ltd
        7.11.1 Sinnovac Biotech Ltd Company Summary
        7.11.2 Sinnovac Biotech Ltd Flu RNA Vaccines Business Overview
        7.11.3 Sinnovac Biotech Ltd Flu RNA Vaccines Major Product Offerings
        7.11.4 Sinnovac Biotech Ltd Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.11.5 Sinnovac Biotech Ltd Key News & Latest Developments
    7.12 Moderna Therapeutics
        7.12.1 Moderna Therapeutics Company Summary
        7.12.2 Moderna Therapeutics Flu RNA Vaccines Business Overview
        7.12.3 Moderna Therapeutics Flu RNA Vaccines Major Product Offerings
        7.12.4 Moderna Therapeutics Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.12.5 Moderna Therapeutics Key News & Latest Developments
    7.13 CureVac
        7.13.1 CureVac Company Summary
        7.13.2 CureVac Flu RNA Vaccines Business Overview
        7.13.3 CureVac Flu RNA Vaccines Major Product Offerings
        7.13.4 CureVac Flu RNA Vaccines Sales and Revenue in Global (2018-2023)
        7.13.5 CureVac Key News & Latest Developments
8 Global Flu RNA Vaccines Production Capacity, Analysis
    8.1 Global Flu RNA Vaccines Production Capacity, 2018-2029
    8.2 Flu RNA Vaccines Production Capacity of Key Manufacturers in Global Market
    8.3 Global Flu RNA Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Flu RNA Vaccines Supply Chain Analysis
    10.1 Flu RNA Vaccines Industry Value Chain
    10.2 Flu RNA Vaccines Upstream Market
    10.3 Flu RNA Vaccines Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Flu RNA Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Flu RNA Vaccines Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?